HIMS · Categories · Downgrades
HIMS - Analyst downgrades
Hims & Hers Health Inc. (HIMS) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for HIMS
- Hims & Hers Health downgraded by BTIG ResearchBTIG Research downgraded Hims & Hers Health from Buy to Neutral
- Hims & Hers Health downgraded by NeedhamNeedham downgraded Hims & Hers Health from Buy to Hold
- Hims & Hers Health downgraded by TD Cowen with a new price targetTD Cowen downgraded Hims & Hers Health from Buy to Hold and set a new price target of $30.00
- Hims & Hers Health downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Hims & Hers Health from Overweight to Equal-Weight and set a new price target of $60.00 from $42.00 previously
- Hims & Hers Health downgraded by Citigroup with a new price targetCitigroup downgraded Hims & Hers Health from Neutral to Sell and set a new price target of $25.00 from $24.00 previously
- Hims & Hers Health downgraded by BofA SecuritiesBofA Securities downgraded Hims & Hers Health from Buy to Underperform
- Hims & Hers Health downgraded by Imperial CapitalImperial Capital downgraded Hims & Hers Health from Outperform to In-line
- Hims & Hers Health downgraded by Citigroup with a new price targetCitigroup downgraded Hims & Hers Health from Buy to Neutral and set a new price target of $20.00 from $16.00 previously
- Hims & Hers Health downgraded by Jefferies with a new price targetJefferies downgraded Hims & Hers Health from Buy to Hold and set a new price target of $15.00 from $17.00 previously
- Hims & Hers Health downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Hims & Hers Health from Overweight to Neutral and set a new price target of $6.00 from $8.00 previously